The Lancet Respiratory Medicine in conversation with Podcast Por The Lancet Group arte de portada

The Lancet Respiratory Medicine in conversation with

The Lancet Respiratory Medicine in conversation with

De: The Lancet Group
Escúchala gratis

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.

Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COVID outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.

© 2026 The Lancet Group Ciencia Ciencias Biológicas Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest

    Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest
    Dec 22 2025

    Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury for the prediction of functional outcome in patients after cardiac arrest using assays that can be analysed on clinically available equipment.

    Click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00363-7/fulltext

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Más Menos
    8 m
  • Sailesh Kotecha on Prematurity-associated lung disease

    Sailesh Kotecha on Prematurity-associated lung disease
    Nov 27 2025

    Prof Sailesh Kotecha joins Diana Stanley to discuss the series on reframing prematurity-associated lung disease as a continuum that begins before birth and evolves throughout life.

    Cick here to read the full series:

    Looking beyond bronchopulmonary dysplasia: prematurity-associated lung disease and its phenotypes
    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00372-8/fulltext

    Trajectories of prematurity-associated lung disease: lifelong lung health
    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00371-6/fulltext

    Management of prematurity-associated lung disease from infancy through to adulthood
    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00369-8/fulltext

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Más Menos
    11 m
  • Neil Greening and Hnin Aung on Multidimensional prognostic risk stratification of COPD exacerbations

    Neil Greening and Hnin Aung on Multidimensional prognostic risk stratification of COPD exacerbations
    Nov 25 2025

    Dr Neil Greening and Dr Hnin Aung join Diana Stanley to discuss a new multidimensional prognostic risk stratification model for COPD exacerbations.


    click here to read the full article:
    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00362-5/fulltext

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Más Menos
    15 m
Todavía no hay opiniones